de Witte L - Search Results

1

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders.

Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A. Oviedo-Salcedo T, et al. Among authors: de witte l. Br J Psychiatry. 2018 May;212(5):318-320. doi: 10.1192/bjp.2018.24. Epub 2018 Mar 28. Br J Psychiatry. 2018. PMID: 29587895

2

Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.

Sommer IE, de Witte L, Begemann M, Kahn RS. Sommer IE, et al. Among authors: de witte l. J Clin Psychiatry. 2012 Apr;73(4):414-9. doi: 10.4088/JCP.10r06823. Epub 2011 Dec 13. J Clin Psychiatry. 2012. PMID: 22225599

3

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Sommer IE, et al. Schizophr Bull. 2014 Jan;40(1):181-91. doi: 10.1093/schbul/sbt139. Epub 2013 Oct 8. Schizophr Bull. 2014. PMID: 24106335 Free PMC article.

4

Cannabidiol as a potential treatment for psychosis.

Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Schubart CD, et al. Among authors: de witte l. Eur Neuropsychopharmacol. 2014 Jan;24(1):51-64. doi: 10.1016/j.euroneuro.2013.11.002. Epub 2013 Nov 15. Eur Neuropsychopharmacol. 2014. PMID: 24309088 Review.

5

Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.

de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. de Witte L, et al. Schizophr Res. 2014 Apr;154(1-3):23-9. doi: 10.1016/j.schres.2014.02.005. Epub 2014 Feb 26. Schizophr Res. 2014. PMID: 24582037 Free article.

6

Genetic liability for schizophrenia predicts risk of immune disorders.

Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Stringer S, et al. Schizophr Res. 2014 Nov;159(2-3):347-52. doi: 10.1016/j.schres.2014.09.004. Epub 2014 Sep 26. Schizophr Res. 2014. PMID: 25266548 Free article. Review.

7

Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies.

de Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P; European Consortium of Autoimmune Mental Disorders (CAIMED). de Witte LD, et al. JAMA Psychiatry. 2015 Jul;72(7):731-3. doi: 10.1001/jamapsychiatry.2015.0526. JAMA Psychiatry. 2015. PMID: 25970159 No abstract available.

8

Early recognition of anti-N-methyl-D-aspartate receptor encephalitis in psychiatric patients.

van Mierlo HC, Titulaer MJ, Kromkamp M, van de Kraats R, van Veelen NM, Palmen SJ, Kahn RS, de Witte LD. van Mierlo HC, et al. Among authors: de witte ld. Acta Psychiatr Scand. 2015 Oct;132(4):312-3. doi: 10.1111/acps.12471. Acta Psychiatr Scand. 2015. PMID: 26371800 No abstract available.

9

No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia.

van Mierlo HC, van Coevorden-Hameete MH, Munting LP, de Graaff E, de Witte L; GROUP investigators. van Mierlo HC, et al. Among authors: de witte l, de graaff e. Eur Neuropsychopharmacol. 2015 Dec;25(12):2326-32. doi: 10.1016/j.euroneuro.2015.09.017. Epub 2015 Oct 8. Eur Neuropsychopharmacol. 2015. PMID: 26482911

10

Characterizing primary human microglia: A comparative study with myeloid subsets and culture models.

Melief J, Sneeboer MA, Litjens M, Ormel PR, Palmen SJ, Huitinga I, Kahn RS, Hol EM, de Witte LD. Melief J, et al. Among authors: de witte ld. Glia. 2016 Nov;64(11):1857-68. doi: 10.1002/glia.23023. Epub 2016 Jul 21. Glia. 2016. PMID: 27442614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters